TY - STD TI - Arnold M, Sierra MS, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global patterns and trends in colorectal cancer incidence and mortality. Gut. 2016. doi:10.1136/gutjnl-2015-310912. UR - http://dx.doi.org/10.1136/gutjnl-2015-310912 ID - ref1 ER - TY - STD TI - Howlader N, Noone A, Krapcho M, Miller D, Bishop K, Altekruse S, Kosary C, Yu M, Ruhl J, Tatalovich Z, Mariotto A, Lewis D, Chen H, Feuer E. SEER Cancer Statistics Review, 1975–2013, based on November 2015 SEER Data Submission. National Cancer Institute. 2016. http://seer.cancer.gov/csr/1975_2013/. Accessed 07 Jul 2016. UR - http://seer.cancer.gov/csr/1975_2013/ ID - ref2 ER - TY - STD TI - Kubisch CH, Crispin A, Mansmann U, Göke B, Kolligs FT. Screening for colorectal cancer is associated with lower disease stage: a population-based study. Clin Gastroenterol H. 2016. doi:10.1016/j.cgh.2016.04.008. UR - http://dx.doi.org/10.1016/j.cgh.2016.04.008 ID - ref3 ER - TY - STD TI - Brenner H, Stock C, Hoffmeister M. Effect of screening sigmoidoscopy and screening colonoscopy on colorectal cancer incidence and mortality: systematic review and meta-analysis of randomised controlled trials and observational studies. BMJ. 2014. doi:10.1136/bmj.g2467. UR - http://dx.doi.org/10.1136/bmj.g2467 ID - ref4 ER - TY - STD TI - Daten und Fakten: Ergebnisse der Studie “Gesundheit in Deutschland Aktuell 2010”: Robert-Koch-Institut; 2012. http://edoc.rki.de/documents/rki_fv/remDCCtjOJxI/PDF/21TgKGZEOWNCY.pdf. Accessed 07 Jul 2016. UR - http://edoc.rki.de/documents/rki_fv/remDCCtjOJxI/PDF/21TgKGZEOWNCY.pdf ID - ref5 ER - TY - STD TI - Stock C, Ihle P, Schubert I, Brenner H. Colonoscopy and fecal occult blood test use in Germany: results from a large insurance-based cohort. Endoscopy. 2011. doi:10.1055/s-0030-1256504. UR - http://dx.doi.org/10.1055/s-0030-1256504 ID - ref6 ER - TY - STD TI - Adler A, Geiger S, Keil A, Bias H, Schatz P, deVos T, Dhein J, Zimmermann M, Tauber R, Wiedenmann B. Improving compliance to colorectal cancer screening using blood and stool based tests in patients refusing screening colonoscopy in Germany. BMC Gastroenterol. 2014. doi:10.1186/1471-230X-14-183. UR - http://dx.doi.org/10.1186/1471-230X-14-183 ID - ref7 ER - TY - STD TI - Shah R, Jones E, Vidart V, Kuppen PJK, Conti JA, Francis NK. Biomarkers for early detection of colorectal cancer and polyps: systematic review. Cancer Epidem Biomar. 2014. doi:10.1158/1055-9965.EPI-14-0412. UR - http://dx.doi.org/10.1158/1055-9965.EPI-14-0412 ID - ref8 ER - TY - STD TI - Church TR, Wandell M, Lofton-Day C, Mongin SJ, Burger M, Payne SR, Castaños-Vélez E, Blumenstein BA, Rösch T, Osborn N, Snover D, Day RW, Ransohoff DF, for the PRESEPT Clinical Study Steering Committee Investigators and Study Team. Prospective evaluation of methylated SEPT9 in plasma for detection of asymptomatic colorectal cancer. Gut. 2014. doi:10.1136/gutjnl-2012-304149. UR - http://dx.doi.org/10.1136/gutjnl-2012-304149 ID - ref9 ER - TY - STD TI - Hundt S, Haug U, Brenner H. Comparative evaluation of immunochemical fecal occult blood tests for colorectal adenoma detection. Ann Intern Med. 2009. doi:10.7326/0003-4819-150-3-200902030-00005. UR - http://dx.doi.org/10.7326/0003-4819-150-3-200902030-00005 ID - ref10 ER - TY - STD TI - Tao S, Haug U, Kuhn K, Brenner H. Comparison and combination of blood-based inflammatory markers with faecal occult blood tests for non-invasive colorectal cancer screening. Brit J Cancer. 2012. doi:10.1038/bjc.2012.104. UR - http://dx.doi.org/10.1038/bjc.2012.104 ID - ref11 ER - TY - STD TI - Heiss JA, Brenner H. Between-array normalization for 450K data. Fron Genet. 2015. doi:10.3389/fgene.2015.00092. UR - http://dx.doi.org/10.3389/fgene.2015.00092 ID - ref12 ER - TY - STD TI - Houseman E, Accomando WP, Koestler DC, Christensen BC, Marsit CJ, Nelson HH, Wiencke JK, Kelsey KT. DNA methylation arrays as surrogate measures of cell mixture distribution. BMC Bioinformatics. 2012. doi:10.1186/1471-2105-13-86. UR - http://dx.doi.org/10.1186/1471-2105-13-86 ID - ref13 ER - TY - STD TI - Bansal A, Pepe MS. Estimating improvement in prediction with matched case-control designs. Lifetime Data Anal. 2013. doi:10.1007/s10985-012-9237-1. UR - http://dx.doi.org/10.1007/s10985-012-9237-1 ID - ref14 ER - TY - STD TI - Werner S, Krause F, Rolny V, Strobl M, Morgenstern D, Datz C, Chen H, Brenner H. Evaluation of a 5-marker blood test for colorectal cancer early detection in a colorectal cancer screening setting. Clin Cancer Res. 2016. doi:10.1158/1078-0432.CCR-15-1268. UR - http://dx.doi.org/10.1158/1078-0432.CCR-15-1268 ID - ref15 ER - TY - STD TI - Imperiale TF, Ransohoff DF, Itzkowitz SH, Levin TR, Lavin P, Lidgard GP, Ahlquist DA, Berger BM. Multitarget stool DNA testing for colorectal-cancer screening. New Engl J Med. 2014. doi:10.1056/NEJMoa1311194. UR - http://dx.doi.org/10.1056/NEJMoa1311194 ID - ref16 ER - TY - STD TI - Brenner H, Tao S. Superior diagnostic performance of faecal immunochemical tests for haemoglobin in a head-to-head comparison with guaiac based faecal occult blood test among 2235 participants of screening colonoscopy. Eur J Cancer. 2013. doi:10.1016/j.ejca.2013.04.023. UR - http://dx.doi.org/10.1016/j.ejca.2013.04.023 ID - ref17 ER - TY - STD TI - Buchen L. Cancer: missing the mark. Nature. 2011. doi:10.1038/471428a. UR - http://dx.doi.org/10.1038/471428a ID - ref18 ER - TY - STD TI - Thorpe JD, Duan X, Forrest R, Lowe K, Brown L, Segal E, Nelson B, Anderson GL, McIntosh M, Urban N. Effects of blood collection conditions on ovarian cancer serum markers. PloS ONE. 2007. doi:10.1371/journal.pone.0001281. UR - http://dx.doi.org/10.1371/journal.pone.0001281 ID - ref19 ER - TY - STD TI - Pepe MS, Fan J, Seymour CW, Li C, Huang Y, Feng Z. Biases introduced by choosing controls to match risk factors of cases in biomarker research. Clin Chem. 2012. doi:10.1373/clinchem.2012.186007. UR - http://dx.doi.org/10.1373/clinchem.2012.186007 ID - ref20 ER - TY - STD TI - Brenner H, Altenhofen L, Tao S. Matching of controls may lead to biased estimates of specificity in the evaluation of cancer screening tests. J Clin Epidemiol. 2013. doi:10.1016/j.jclinepi.2012.09.00810.1016/j.jclinepi.2012.09.008. UR - http://dx.doi.org/10.1016/j.jclinepi.2012.09.00810.1016/j.jclinepi.2012.09.008 ID - ref21 ER - TY - STD TI - Jaffe AE, Irizarry RA. Accounting for cellular heterogeneity is critical in epigenome-wide association studies. Genome Biol. 2014. doi:10.1186/gb-2014-15-2-r31. UR - http://dx.doi.org/10.1186/gb-2014-15-2-r31 ID - ref22 ER - TY - STD TI - Kilincalp S, Çoban Ş, Akinci H, Hamamcı M, Karaahmet F, Coşkun Y, Üstün Y, Şimşek Z, Erarslan E, Yüksel İ. Neutrophil/lymphocyte ratio, platelet/lymphocyte ratio, and mean platelet volume as potential biomarkers for early detection and monitoring of colorectal adenocarcinoma. Eur J Cancer Prev. 2015. doi:10.1097/CEJ.0000000000000092. UR - http://dx.doi.org/10.1097/CEJ.0000000000000092 ID - ref23 ER - TY - STD TI - Buhule OD, Minster RL, Hawley NL, Medvedovic M, Sun G, Viali S, Deka R, McGarvey ST, Weeks DE. Stratified randomization controls better for batch effects in 450K methylation analysis: a cautionary tale. Fron Genet. 2014. doi:10.3389/fgene.2014.00354. UR - http://dx.doi.org/10.3389/fgene.2014.00354 ID - ref24 ER - TY - STD TI - van den Boogaart KG, Tolosana-Delgado R. Analyzing compositional data with R: Springer Berlin Heidelberg; 2013. doi:10.1007/978-3-642-36809-7. UR - http://dx.doi.org/10.1007/978-3-642-36809-7 ID - ref25 ER -